Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cansu Karakas

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancers|March 22, 2020
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of AgeSimon J Johnston, Binafsha M Syed, Ruth M Parks, et al.
Oncogenesis|May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancersAmriti R Lulla, Said Akli, Cansu Karakas, et al.
Annals of Surgery|August 23, 2019
Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast CancerCansu Karakas, Ashleigh M Francis, Min Jin Ha, et al.
Cancers|April 30, 2021
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or <i>BRCA1</i> AlterationXian Chen, Dong Yang, Jason P W Carey, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 11, 2026
HER2 In Situ Hybridization: Validation and Implementation of Brightfield Assay in a US Academic Pathology LaboratoryMegan L Troxell, Alex M Dussaq, Joanna Solarewicz, et al.
Oncotarget|January 21, 2017
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancerAngela Alexander, Cansu Karakas, Xian Chen, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
Cancer Research|August 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.
Cancer Research|January 5, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real TimeTuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancers|March 22, 2020
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of AgeSimon J Johnston, Binafsha M Syed, Ruth M Parks, et al.
Oncogenesis|May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancersAmriti R Lulla, Said Akli, Cansu Karakas, et al.
Annals of Surgery|August 23, 2019
Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast CancerCansu Karakas, Ashleigh M Francis, Min Jin Ha, et al.
Cancers|April 30, 2021
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or <i>BRCA1</i> AlterationXian Chen, Dong Yang, Jason P W Carey, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 11, 2026
HER2 In Situ Hybridization: Validation and Implementation of Brightfield Assay in a US Academic Pathology LaboratoryMegan L Troxell, Alex M Dussaq, Joanna Solarewicz, et al.
Oncotarget|January 21, 2017
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancerAngela Alexander, Cansu Karakas, Xian Chen, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
Cancer Research|August 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.
Cancer Research|January 5, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real TimeTuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui, et al.
Pageof 4